Beta
Saccharomyces boulardii CNCM I-745
supplementBeneficial yeast for antibiotic-associated diarrhea.
Reported Benefits
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota during Genesis®-based nutritional therapy in healthy and critically ill patients
Konieczny et al.
Study in healthy controls showed slight nonsignificant increase in short-chain fatty acids after 6 days, supporting microbiota regeneration during nutritional therapy.
Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Double-blind, randomized, placebo-controlled trial evaluating efficacy on global IBS symptoms using IBS-SSS after 8 weeks in IBS patients, many of whom may have baseline healthy gut function outside flares.
Effectiveness of Saccharomyces boulardii CNCM I-745 in Adult Patients with Diarrhoea: A Real-World Comparative Study
McRonald FE, et al.
Retrospective study in 1727 adults with acute diarrhea showed 77.8% resolved symptoms with S. boulardii versus 15.8% in controls after median 5 days, including those on antibiotics, indicating rapid restoration in otherwise healthy individuals.
Effectiveness of Saccharomyces boulardii CNCM I-745 in Adult Patients with Diarrhoea: A Real-World Comparative Study
McRonald FE, et al.
Retrospective study in 1727 adults with acute diarrhea showed 77.8% resolved symptoms with S. boulardii versus 15.8% in controls after median 5 days, including those on antibiotics, indicating rapid restoration in otherwise healthy individuals.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research (3 studies)
Community updates
No updates yet for this supplement.
Be the first to share your experience!